Phagocytic response of bovine polymorphonuclear leukocytes to different incubation conditions and following exposure to some effectors of phagocytosis and different anticoagulants in vitro.
The ability of bovine polymorphonuclear leukocytes (PMN) to phagocytose fluorescent beads in vitro was studied using flow cytometry. The effects of varying laboratory conditions (bead:PMN ratio, length of incubation, and temperature) were first determined, then the effects of lipopolysaccharide (LPS), phorbol myristate acetate (PMA), cytochalasin B, and formyl-met-leu-phe (fMLP) on phagocytosis were evaluated. The recommended bead:PMN ratio, incubation period, and incubation temperature are 20:1, 30 min, and 38.5 degrees C, respectively. Lipopolysaccharide increased phagocytosis at a relatively high minimum dose; PMA increased phagocytosis even at low doses; cytochalasin B increased and decreased phagocytosis at low and high doses, respectively; and fMLP had no significant effect on phagocytosis. Also, the effects of ethylene diamine tetraacetic acid (EDTA) and acid citrate dextrose (ACD) as anticoagulants were compared with heparin-treated blood PMNs. Both EDTA and ACD decreased phagocytosis. Although there are reports that demonstrated that heparin reduced PMN phagocytosis, at least among the 3 anticoagulants used, heparin remains to be the standard anticoagulant for the study of PMN phagocytosis.
Ducusin
R J
RJ
Laboratory of Veterinary Internal Medicine, Obihiro University of Agriculture and Veterinary Medicine, Hokkaido, Japan. s04055@st.obihiro.ac.jp
Sarashina
T
T
Uzuka
Y
Y
Tanabe
S
S
Ohtani
M
M
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology; D002417:Cattle / Q000097:blood / Q000276:immunology*; D003571:Cytochalasin B / Q000494:pharmacology; D005260:Female; D005434:Flow Cytometry / Q000662:veterinary; D008070:Lipopolysaccharides / Q000494:pharmacology; D009504:Neutrophils / Q000276:immunology*; D010587:Phagocytosis / Q000187:drug effects; D013696:Temperature; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013997:Time Factors
D000925:Anticoagulants; D008070:Lipopolysaccharides; D003571:Cytochalasin B; D013755:Tetradecanoylphorbol Acetate